Gladius Capital Management LP Organon & Co. Transaction History
Gladius Capital Management LP
- $166 Million
- Q3 2024
A detailed history of Gladius Capital Management LP transactions in Organon & Co. stock. As of the latest transaction made, Gladius Capital Management LP holds 1,456 shares of OGN stock, worth $23,383. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,456
Previous 1,456
-0.0%
Holding current value
$23,383
Previous $27,000
-0.0%
% of portfolio
0.02%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding OGN
# of Institutions
791Shares Held
201MCall Options Held
1.71MPut Options Held
865K-
Black Rock Inc. New York, NY32.6MShares$523 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.2MShares$485 Million0.01% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.2MShares$179 Million0.41% of portfolio
-
Massachusetts Financial Services CO Boston, MA9.76MShares$157 Million0.06% of portfolio
-
State Street Corp Boston, MA8.98MShares$144 Million0.01% of portfolio
About Organon & Co.
- Ticker OGN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 254,330,000
- Market Cap $4.08B
- Description
- Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...